Obstructive sleep apnoea/hypopnoea syndrome linked to NTG

Article

Moderate and severe obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is strongly linked to normal tension glaucoma (NTG).

Moderate and severe obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is strongly linked to normal tension glaucoma (NTG), claims a study in the Journal of Glaucoma.

Dr Pei-Wen Lin et al., Department of Ophthalmology, Kaohsiung Medical Center, Taiwan, conducted a polysomnographic exam on 256 participants to diagnose OSAHS. A complete ophthalmologic examination was performed on all participants. This included best-corrected visual acuity (BCVA), intraocular pressure, slit lamp biomicroscopy, gonioscopy, fundoscopy, automated visual field (VF) and retinal nerve fibre layer (RNFL) evaluation.

OSAHS was found in 209 patients out of the total examined and 38 were placed into the normal group. In the OSAHS group NTG was discovered in 12 patients. The prevalence was 5.7% - significantly higher than the normal group. Out of the NTG patients examined, one was found to have mild OSAHS, three were moderate and eight were severe.

Prevalence of NTG in moderate and severe OSAHS patients was 7.1%. This was significantly higher than normal and mild OSAHS patients. There were no incidences of glaucoma in the normal group.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.